News Headlines Article

Rising U.S. Drug Prices Are Focus of Research Grant
The Wall Street Journal

A Houston philanthropist couple plans to announce Tuesday that they are providing a $5.2 million grant to a Boston nonprofit, the Institute of Clinical and Economic Review, to expand the group’s research evaluating whether new drugs are worth their price tags.

ICER research has already made a mark: Some U.S. drug-plan managers credited the nonprofit last year with helping them secure big discounts on expensive new hepatitis C drugs, after ICER concluded the therapies would only be cost-effective at half their price.

Commands